NLM Digital Collections

Search

Start Over Subjects United States ✖Remove constraint Subjects: United States Copyright Public domain ✖Remove constraint Copyright: Public domain Recently Added Within 6 Months ✖Remove constraint Recently Added: Within 6 Months

102. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products: guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):
Biological Products
Clinical Trials as Topic
Data Analysis
Decision Making
Drug Approval
Drug Industry
Drug and Narcotic Control
Government Regulation
United States
United States.

103. Wholesale distributor verification requirement for saleable returned drug product and dispenser verification requirements when investigating a suspect or illegitimate product: compliance policies : guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):
Counterfeit Drugs
Drug Industry
Drug and Narcotic Control
Fraud
Government Regulation
Substandard Drugs
United States
United States.

105. Voluntary consensus standards recognition program for regenerative medicine therapies: guidance for industry

Publication:
Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023
Subject(s):
Drug Industry
Government Regulation
Reference Standards
Regenerative Medicine -- legislation & jurisprudence
Regenerative Medicine -- standards
Voluntary Programs
United States
Center for Biologics Evaluation and Research (U.S.)

109. Compliance policy regarding blood and blood component donation suitability, donor eligibility and source plasma quarantine hold requirements: guidance for industry

Publication:
Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023
Subject(s):
Blood Banking -- standards
Blood Donation -- standards
Blood Donors
Donor Selection -- standards
Government Regulation
Guideline Adherence
Plasma
United States

111. Human prescription drug and biological products: labeling for dosing based on weight or body surface area for ready-to-use containers : “dose banding” : guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, October 2023
Subject(s):
Biological Products -- administration & dosage
Drug Dosage Calculations
Drug Industry
Drug Labeling
Drug Packaging
Government Regulation
Injections -- standards
Prescription Drugs -- administration & dosage
Product Labeling
Product Packaging
United States

119. Income of working-age veterans receiving disability compensation

Author(s):
Bass, Elizabeth, (Economist), author
Golding, Heidi L. W., author
Publication:
[Washington, D.C.] : Congressional Budget Office, December 2023
Subject(s):
Disabled Persons -- statistics & numerical data
Income -- statistics & numerical data
Insurance, Disability -- statistics & numerical data
Veterans -- statistics & numerical data
United States

120. Exploring the effects of Medicaid during childhood on the economy and the budget

Author(s):
Ash, Elizabeth, (Of Congressional Budget Office), author
Carrinton, William, author
Heller, Rebecca, (Of Congressional Budget Office), author
Hwang, Grace, (Of Congressional Budget Office), author
Publication:
[Washington, DC] : Congressional Budget Office, November 2023
Subject(s):
Budgets
Child
Federal Government
Income
Medicaid -- economics
Taxes
United States

122. Alternative payment models and the slowdown in federal health care spending: testimony before the Committee on the Budget, United States Senate

Author(s):
Cohen, Michael, (Of Congressional Budget Office), author
White, Chapin, author
Publication:
[Washington, D.C.] : Congressional Budget Office, October 18, 2023
Subject(s):
Accountable Care Organizations
Federal Government
Health Expenditures -- trends
Reimbursement Mechanisms
United States

123. Federal subsidies for health insurance: 2023 to 2033

Author(s):
Hale, Jessica, author
Vreeland, Emily, author
Publication:
[Washington, D.C.] : Congressional Budget Office, September 2023
Subject(s):
Financing, Government
Health Insurance Exchanges -- economics
Health Insurance Exchanges -- statistics & numerical data
Insurance, Health -- economics
Insurance, Health -- statistics & numerical data
Insurance, Health -- trends
Medical Assistance -- economics
Medical Assistance -- statistics & numerical data
Medical Assistance -- trends
United States

124. Federal budgetary effects of the activities of the Center for Medicare & Medicaid Innovation

Author(s):
Cohen, Michael, (Of Congressional Budget Office), author
Hall, Cornelia, author
Matthews, Rachel, (Of Health Management Associates), author
Robillard, Lara, author
Hale, Jessica, author
Zhang, Katie, author
Publication:
[Washington, D.C.] : Congressional Budget Office, September 2023
Subject(s):
Budgets -- trends
Federal Government
Models, Economic
United States
Center for Medicare & Medicaid Innovation (U.S.)

126. Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
Drug Costs
Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)

127. CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
Government Regulation
Legislation, Medical
Politics
Professional Misconduct
United States
United States.
United States. Department of Health and Human Services

128. Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, September 19, 2023
Subject(s):
Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Drugs -- economics
United States

129. COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
COVID-19
Disaster Planning -- economics
Disaster Planning -- organization & administration
Fraud -- prevention & control
Government Regulation
Health Personnel -- economics
Legislation, Medical
United States
United States. Health Resources and Services Administration

130. Medicaid program integrity: Opportunities exist for CMS to strengthen use of state auditor findings and collaboration : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
Financial Audit -- legislation & jurisprudence
Financial Audit -- trends
Government Programs
Government Regulation
Legislation, Medical
Medicaid
State Health Planning and Development Agencies
United States
Centers for Medicare & Medicaid Services (U.S.)

131. Nursing homes: Limitations of using CMS data to identify private equity and other ownership : report to the Ranking Member, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
Data Accuracy
Government Regulation
Legislation, Medical
Nursing Homes -- economics
Nursing Homes -- legislation & jurisprudence
Nursing Homes -- organization & administration
United States
Centers for Medicare & Medicaid Services (U.S.)

132. COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
COVID-19 Vaccines -- supply & distribution
Global Health
Government Regulation
Immunization Programs
International Cooperation
Legislation, Medical
United States
United States. Agency for International Development

135. Medicare: Performance-based and geographic adjustments to physician payments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, October 19, 2023
Subject(s):
Access to Primary Care -- statistics & numerical data
Government Regulation
Health Inequities
Health Promotion -- economics
Medicare
Primary Prevention
United States

136. Mental health services: State should collect ongoing feedback to ensure overseas employees’ needs are being met : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2023
Subject(s):
Foreign Professional Personnel -- psychology
Government Employees -- psychology
Government Regulation
Legislation, Medical
Mental Health Services
Workload
United States
United States. Agency for International Development

138. Indian Health Service: Many federal facilities are in fair or poor condition and better data are needed on medical equipment : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, November 2023
Subject(s):
Equipment and Supplies
Facility Regulation and Control
Government Regulation
Health Facility Administration
Health Facility Environment
Legislation, Medical
United States
United States. Indian Health Service

139. Veterans health care: VA has taken steps to improve its appointment scheduling process, but additional actions are needed : testimony before the Special Committee on Aging, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, May 17, 2023
Subject(s):
Appointments and Schedules
Government Regulation
Legislation, Medical
Veterans Health Services -- organization & administration
United States
United States. Department of Veterans Affairs

140. FDA could take stronger enforcement action against tobacco retailers with histories of sales to youth and other violations

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
Government Regulation
Health Policy
Tobacco Control
Tobacco Industry -- legislation & jurisprudence
United States
United States. Food and Drug Administration

141. CDC provided oversight and assistance: however, ELC recipients still faced challenges in implementing COVID-19 screening testing programs

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
COVID-19 Testing -- instrumentation
Government Programs
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

143. Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
Ethnic and Racial Minorities -- statistics & numerical data
Government Regulation
Health Inequities
Healthcare Disparities
Medicaid
Morphinans -- supply & distribution
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

144. Medicare could save millions if it implements an expanded hospital transfer payment policy for early discharges to post acute care

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):
Financial Audit
Government Regulation
Medicare Part A -- economics
Medicare Part A -- organization & administration
Patient Transfer -- economics
Subacute Care -- economics
United States

147. States face ongoing challenges in meeting third-party liability requirements for ensuring that Medicaid functions as the payer of last resort

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):
Financial Audit
Government Regulation
Insurance, Health, Reimbursement -- legislation & jurisprudence
Medicaid -- economics
State Health Plans
United States

148. Trends in ownership structures of U.S. nursing homes and the relationship with facility traits and quality of care (2013-2022)

Author(s):
Stevenson, David G. (David George), author
Peterson, Hannah, author
Skinner, Robert, (Of Vanderbilt School of Medicine), author
Ndrianasy, Estrella, author
Braun, Robert Tyler, author
Unruh, Mark, author
Fernandez, Rahul, author
Publication:
Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy, November 13, 2023
Subject(s):
Nursing Homes -- organization & administration
Ownership -- trends
Quality of Health Care
United States

149. Community care hubs: a promising model for health and social care coordination

Author(s):
Breslau, Joshua, author
Rasmussen, Petra W., author
Qureshi, Nabeel Shariq, author
Peet, Evan D., author
Publication:
[Washington, D.C.] : Office of the Assistant Secretary for Planning and Evaluation, Administration for Community Living, U.S. Deparment of Health and Human Serivcies, November 2023
Subject(s):
Community Health Services -- organization & administration
Social Determinants of Health
Social Support
United States

Refine by:

more »

more »

more »

more »

Current results range from 1869 to 2024